NCT06736418
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06736418
Title Study of 225Ac-ABD147 to Establish Optimal Dose in Patients with SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Abdera Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Hoag Memorial Hospital Presbyterian RECRUITING Newport Beach California 92663 United States Details
University of California, San Francisco RECRUITING San Francisco California 94143 United States Details
University of California, Los Angeles RECRUITING Santa Monica California 90404 United States Details
Mayo Clinic - Jacksonville RECRUITING Jacksonville Florida 32224 United States Details
Sylvester Comprehensive Cancer Center, Univ of Miami RECRUITING Miami Florida 33136 United States Details
Florida Cancer Specialists - Sarasota RECRUITING Sarasota Florida 34232 United States Details
United Theranostics RECRUITING Glen Burnie Maryland 21061 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester RECRUITING Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
MD Anderson RECRUITING Houston Texas 77030 United States Details
Huntsman Cancer Institute RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field